Showing results (591-600 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|December 8, 2024
Effect of a multicomponent, person-centred care intervention on client experience and HIV treatment outcomes in Zambia: a stepped-wedge, cluster-randomised trialKombatende Sikombe, Aaloke Mody, Charles W Goss, et al.
The Lancet. HIV|December 4, 2024
HIV incidence and factors associated with HIV risk among people who inject drugs engaged with harm-reduction programmes in four provinces in South Africa: a retrospective cohort studyAdelina Artenie, Rachel Perry, Memory Mahaso, et al.
The Lancet. HIV|November 30, 2024
Fostering healthy cognitive ageing in people living with HIVLucette A Cysique, Jules Levin, Chris Howard, et al.
The Lancet. HIV|November 28, 2024
Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
The Lancet. HIV|November 13, 2024
Interventions to ensure access to and continuity of HIV care for international migrants: an evidence synthesisAlena Kamenshchikova, Charlotte M M Peters, Christiana Nöstlinger, et al.
The Lancet. HIV|November 13, 2024
Humanising and optimising HIV health care for refugees and asylum seekersClaudia P Cortes, Omar Sued, William C W Wong, et al.
The Lancet. HIV|October 3, 2025
The impact of cuts in the US President's Emergency Plan for AIDS Relief funding for HIV pre-exposure prophylaxis in sub-Saharan Africa: a modelling studyJack Stone, Kennedy Kipkoech Mutai, Adelina Artenie, et al.
The Lancet. HIV|December 28, 2020
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort studyColette Smit, Anders Boyd, Bart J A Rijnders, et al.
The Lancet. HIV|December 10, 2019
Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programmeJohn Kinuthia, Jillian Pintye, Felix Abuna, et al.
The Lancet. HIV|April 3, 2020
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trialKelly E Dooley, Radojkam Savic, Akshay Gupte, et al.
Pageof 79